Rectal Cancer Treatment (eBook)

Contents 5
Postoperative Pathophysiology and Choice of Incision 8
Fast-Track Colonic Surgery: Status and Perspectives 15
Fast-Track Surgery: The Heidelberg Experience 21
Rectal Cancer: A Compartmental Disease. TheMesorectum and Mesorectal Lymph Nodes 28
The Pathological Assessment of Total Mesorectal Excision: What Are the Relevant Resection Margins? 37
Is the Lateral Lymph Node Compartment Relevant? 47
Diagnostics of Rectal Cancer: Endorectal Ultrasound 53
Preoperative Staging of Rectal Cancer: The MERCURY Research Project 65
Rectal Cancer Management: Europe Is Ahead 82
Teaching Efforts to Spread TME Surgery in Sweden 89
Learning Curve: The Surgeon as a Prognostic Factor in Colorectal Cancer Surgery 93
Surgical Results of Total Mesorectal Excision for Rectal Cancer in a Specialised Colorectal Unit 112
Total Mesorectal Excision: The Heidelberg Results after TME 119
Is Local Excision of T2/T3 Rectal Cancers Adequate? 127
Operative Treatment of Locally Recurrent Rectal Cancer 143
Laparoscopic TME: Better Vision, Better Results? 155
Laparoscopic TME— The Surgeon’s or the Patient’s Preference 165
Laparoscopic Total Mesorectal Excision— The Turin Experience 174
Evacuation of Neorectal Reservoirs after TME 187
Long-Term Functional Results After Straight or Colonic J- Pouch Coloanal Anastomosis 198
Urinary and Sexual Function After Total Mesorectal Excision 203
Functional Results of the Colon J-Pouch Versus Transverse Coloplasty Pouch in Heidelberg 212
Indications for Neoadjuvant Long-Term Radiotherapy 219
Neoadjuvant Radiotherapy and Radiochemotherapy for Rectal Cancer 228
Adjuvant Radiochemotherapy for Rectal Cancer 238
Intraoperative Radiotherapy for Rectal Carcinoma 245
Indications and Effect on Survival of Standard Chemotherapy in Advanced Colorectal Cancer 252
New Chemotherapeutic Strategies in Colorectal Cancer 257
Active Specific Immunotherapy in Colon Cancer 267
Radiofrequency Ablation in Metastatic Disease 275